SAN DIEGO (AP) _ Mast Therapeutics Inc. (MSTX) on Monday reported a loss of $6 million in its fourth quarter.
The San Diego-based company said it had a loss of 2 cents per share.
The biopharmaceutical company posted revenue of $83,000 in the period.
For the year, the company reported that its loss widened to $36.1 million, or 17 cents per share. Revenue was reported as $128,000.
In the final minutes of trading on Monday, the company's shares hit 12 cents. A year ago, they were trading at 27 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MSTX at https://www.zacks.com/ap/MSTX
Keywords: Mast Therapeutics, Earnings Report